The Royal Surrey NHS Foundation Trust is an award-winning, multi-site healthcare provider operating from a main acute site in Guildford and across community and primary care sites in Surrey. The Trust also provides specialist services in certain disciplines to a population of up to three million, as part of the Surrey and Sussex Cancer Alliance. We are a Trust that works collaboratively – as a key player within the Surrey Heartlands Integrated Care System and as a partner of the University of Surrey, a relationship which will only be strengthened with the impending opening of their new Medical School.
Our Board is an inclusive and collegiate space, where colleagues support, but also challenge each other to deliver better outcomes and experiences for our staff and patients. We are looking to appoint a new Non-Executive Director (NED) to join the Board. We are specifically looking for an innovative, forward looking, and engaging NED, with the ability to chair our Audit Committee and form the partnerships necessary with both internal and external stakeholders who help support the audit function. Previous Board level experience and experience of risk management and assurance in a complex working environment is highly desirable.
Applicants must have a genuine commitment to patients and the promotion of excellent health care services; they must be able to embrace and champion the Trust’s values; and they must be able to add value, independence and rigour to strategy development.
We are keen to consider candidates who can also bring diversity of thought, background, and protected characteristics – while the Board as a whole currently has good age and gender diversity, we are less representative, for example, of the ethnic diversity we see in our staff and in the communities we serve.
For a confidential conversation please contact our recruitment partners Rhiannon Smith or Jenny Adrian from Hunter Healthcare at jadrian@hunter-healthcare.com or on 07939 250362.
Please click here for the candidate information pack
| Date | Event |
|---|---|
| 22 September 2023 | Closing Date |
| w/c 25 September | Longlisting |
| w/c 2 October | Shortlisting |
| TBC | Stakeholder Panel |
| w/c 16 October | Interview Panel |